HMGA2 and mTOR: Key Regulators of Cellular Aging and Proliferation
Researchers have identified a crucial protein, HMGA2, that significantly influences the aging process and the proliferation of human cells, particularly those derived from umbilical cord blood. Manipulating HMGA2 levels in laboratory settings has demonstrated a notable impact on cellular aging and growth, offering potential insights into regenerative medicine and age-related diseases.
Understanding HMGA2 and its Role in Cellular Processes
HMGA2, or high-mobility group protein A2, is described as an “architectural transcription factor.”1 This means it affects DNA structure and influences which genes are activated or deactivated. Studies focusing on human umbilical cord blood-derived stromal cells (hUCBSCs) – a type of stem cell with regenerative potential – have shown that increasing HMGA2 levels enhances cell multiplication and can even reverse signs of aging in vitro (in a controlled laboratory environment).2
The mTOR/p70S6K Signaling Pathway: A Central Mechanism
The effects of HMGA2 are largely mediated through the mTOR/p70S6K signaling pathway.1 HMGA2 overexpression activates this pathway, which subsequently suppresses the expression of two key proteins involved in cellular aging: p16INK4A and p21CIP1/WAF1.2 These proteins normally act as brakes on cell division, so reducing their levels allows cells to continue dividing for a longer period.
HMGA2’s Impact on Cell Cycle Regulation
Increased HMGA2 expression correlates with higher levels of cyclin E and CDC25A, proteins that promote cell cycle progression and division.2 Simultaneously, there is a decrease in cyclin-dependent kinase inhibitors, which contribute to aging by slowing down cell division.2
The Role of HMGA2 Inhibition
Conversely, inhibiting HMGA2 compromises cell proliferation and adipogenic differentiation in early-stage hUCBSCs.2 This suggests that HMGA2 is not only critical for promoting cell growth but also for maintaining the developmental potential of these cells.
Connection to Other Regulatory Pathways
Research indicates a connection between HMGA2, the mTOR/p70S6K pathway, and microRNA (miRNA) regulation. Specifically, miR-195 appears to play a role in regulating proliferation and apoptosis by targeting HMGA2.3 HMGA2 can restore the inhibitory effect of miR-195 on the phosphorylation of mTOR and p70S6K. Inhibiting the mTOR/p70S6K pathway with rapamycin has been shown to decrease cell proliferation and promote apoptosis.
Future Directions
The interplay between HMGA2, the mTOR/p70S6K pathway, and other regulatory mechanisms like miRNAs highlights the complexity of cellular aging and proliferation. Further research is needed to fully understand these interactions and explore the potential for therapeutic interventions targeting HMGA2 and the mTOR pathway to promote healthy aging and regenerative medicine.